Effect of tiotropium/olodaterol combination therapy on long-term heart rate and blood pressure in COPD patients

S. Andreas (Göttingen, Germany), L. Mcgarvey (Belfast, United Kingdom), U. Bothner (Ingelheim am Rhein, Germany), M. Trampisch (Ingelheim am Rhein, Germany), A. De La Hoz (Ingelheim am Rhein, Germany), M. Fležar (Golnik, Slovakia), . Alter (Marburg, Germany), R. Buhl (Mainz, Germany)

Source: International Congress 2018 – COPD management
Session: COPD management
Session type: Thematic Poster
Number: 4391
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Andreas (Göttingen, Germany), L. Mcgarvey (Belfast, United Kingdom), U. Bothner (Ingelheim am Rhein, Germany), M. Trampisch (Ingelheim am Rhein, Germany), A. De La Hoz (Ingelheim am Rhein, Germany), M. Fležar (Golnik, Slovakia), . Alter (Marburg, Germany), R. Buhl (Mainz, Germany). Effect of tiotropium/olodaterol combination therapy on long-term heart rate and blood pressure in COPD patients. 4391

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effects of a physical training protocol on heart rate kinetics and heart rate variability indexes in patients with pulmonary arterial hypertension.
Source: International Congress 2019 – Exercise and rehabilitation in patients with acute and chronic respiratory diseases
Year: 2019

Effect of long-term specific therapy in a cohort of 33 patients with pulmonary arterial hypertension of various etiologies
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010

Influence of resistance training on heart rate variability in the difficult-to-control asthmatic patients.
Source: Virtual Congress 2020 – Novel insights into exercise training
Year: 2020


Effect of varying the initial flow rate during noninvasive pressure support ventilation in COPD patients recovering from acute respiratory failure
Source: Annual Congress 2003 - Physiology of NIV: understanding the effects and chosing the best settings
Year: 2003


Impact of long-term oxygen therapy on diaphragm function and pulmonary-cardiac hemodynamics in patients with COPD with hypoxemia (3-year assessment)
Source: International Congress 2019 – Lung function and respiratory muscle testing
Year: 2019

Blood pressure and heart rate variability response to noninvasive ventilation in patients with exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Clinical applications of noninvasive ventilation
Year: 2007


Response to exercise in patients with pulmonary arterial hypertension treated with combination therapy
Source: ERJ Open Res, 7 (1) 00725-2020; 10.1183/23120541.00725-2020
Year: 2021



Short term effects of acute laboratory induced hypoxemia on heart rate and blood pressure variability in healthy subjects
Source: Eur Respir J 2006; 28: Suppl. 50, 631s
Year: 2006

The effect of long-term specific therapy on clinical outcome, echocardiographic and sympatho-vagal balance as assessed by heart rate variability in pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary vascular diseases
Year: 2009


Effect of long-term oxygen therapy on exercise capacity and quality of life in exercise-desaturating patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension: a randomized-sham-controlled cross-over trial
Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension
Year: 2017

Long-term effect of CPAP on systemic arterial hypertension development and control in a single cohort of 422 OSAH patients
Source: Annual Congress 2010 - Complex sleep apnoea, opioids, adaptive servoventilation, bilateral positive airway pressure and continuous positive airway pressure
Year: 2010

Successful pregnancy outcome in patients with pulmonary arterial hypertension receiving prostayclin therapy
Source: Annual Congress 2004 - Pulmonary hypertension
Year: 2004


Effects of long-acting inhaled β-adrenergic and anticholinergic drugs on respiratory function and arterial blood gases in patients with COPD
Source: Annual Congress 2006 - Recent advances in the treatment of COPD
Year: 2006


The effects of beta-blocker therapy on heart rate, symptoms and exercise in pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Year: 2013


High blood pressure, antihypertensive medication and lung function in a general adult population
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011

Impact of long-term oxygen therapy on morphological changes of red blood cells and NT-proBNP level in COPD patients.
Source: International Congress 2017 – COPD biomarkers
Year: 2017


Cardiovascular profile of modafinil: effects on blood pressure and heart rate
Source: Eur Respir J 2004; 24: Suppl. 48, 565s
Year: 2004

Prognostic implications of delayed heart rate recovery from maximal-incremental exercise in patients with pulmonary arterial hypertension
Source: Annual Congress 2012 - Limiting factors in exercise
Year: 2012


Efficacy and compliance with noninvasive positive pressure ventilation in patients with chronic respiratory failure
Source: Eur Respir J 2001; 18: Suppl. 33, 403s
Year: 2001

Effects of pulmonary rehabilitation in COPD patients with increased baseline arterial stiffness: The CIROCO study
Source: Annual Congress 2010 - Pulmonary rehabilitation and chronic care: new developments in interventions, assessment and care
Year: 2010